Variant estrogen receptor-α messenger RNA expression in hormone-independent human breast cancer cells

被引:5
作者
Coutts, AS [1 ]
Leygue, E [1 ]
Murphy, LC [1 ]
机构
[1] Univ Manitoba, Dept Biochem & Mol Biol, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1677/jme.0.0230325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T5-PRF cells are insensitive to the growth-stimulatory effects of estrogen while still retaining expression of estrogen receptor-alpha (ER-alpha). In the apparent absence of ligand, T5-PRF cells have a 3.6 +/- 0.5 (S.E.M.)-fold increased basal ER-alpha activity and elevated basal progesterone receptor levels compared with the parent, estrogen-sensitive, T5 cells. Long-range ER-alpha reverse transcription-PCR was performed to characterize variant ER-alpha mRNA expression in the two cell lines. An increased relative expression of an exon 3/4-deleted ER-alpha mRNA variant was found in T5-PRF. Recombinant expression of this ER-alpha variant resulted in significantly increased estrogen responsiveness, as well as a trend to increased basal ligand-independent activity when expressed with wild-type ER-alpha in ER-negative cell lines, as well as significantly increasing both ligand-independent and estrogen-induced ER-alpha transcriptional activity when expressed in parental T5 cells. These results suggest a role for altered variant ER-alpha in ligand-independent activation of ER-alpha which may contribute to hormone independence in breast tumors.
引用
收藏
页码:325 / 336
页数:12
相关论文
共 65 条
[1]  
BRUNNER N, 1993, CANCER RES, V53, P283
[2]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[3]  
CASTLES CG, 1993, CANCER RES, V53, P5934
[4]   THE PROCESS OF MALIGNANT PROGRESSION IN HUMAN BREAST-CANCER [J].
CLARKE, R ;
DICKSON, RB ;
BRUNNER, N .
ANNALS OF ONCOLOGY, 1990, 1 (06) :401-407
[5]  
Coutts AS, 1996, J CELL BIOCHEM, V63, P174, DOI 10.1002/(SICI)1097-4644(19961101)63:2<174::AID-JCB5>3.0.CO
[6]  
2-V
[7]  
Coutts AS, 1998, CANCER RES, V58, P4071
[8]  
DAFFADA AAI, 1995, CANCER RES, V55, P288
[9]   Presence of exon 5-deleted oestrogen receptor in human breast cancer: Functional analysis and clinical significance [J].
Desai, AJ ;
Luqmani, YA ;
Walters, JE ;
Coope, RC ;
Dagg, B ;
Gomm, JJ ;
Pace, PE ;
Rees, CN ;
Thirunavukkarasu, V ;
Shousha, S ;
Groome, NP ;
Coombes, R ;
Ali, S .
BRITISH JOURNAL OF CANCER, 1997, 75 (08) :1173-1184
[10]  
DICKSON RB, 1991, BREAST, P363